Clin2
NCT07003880Possibly a fitNot yet recruiting

Inhaled pain relief for ear, nose, and throat procedures

All Adult Patients Undergoing an Otolaryngology Procedure With Inhaled Methoxyflurane as an Adjunct to Topical or Local Anesthesia

Part of Ear, nose & throat clinical trials.

This trial tests a pain-relief medicine called Penthrox (methoxyflurane) that you breathe in through a handheld inhaler. It is used alongside numbing medicine during common ear, nose, or throat procedures to help reduce pain and anxiety. The goal is to see if it works well and is safe for these procedures.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You are having one of these procedures: removing a skin lesion, a biopsy (taking a small tissue sample), a throat or voice box injection or biopsy, ear tube placement, reducing nasal turbinates, or inserting a septal button.
  • You are not pregnant, planning to become pregnant, or breastfeeding.
  • You do not have kidney problems, liver problems from past anesthesia, or a history of malignant hyperthermia (a rare reaction to anesthesia).
  • You are not currently taking tetracycline antibiotics.
  • You are able to answer a short questionnaire after the procedure.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06750302Recruiting· Phase 1/Phase 2
Penthrox vs placebo for sinus surgery pain

This trial tests if a pain reliever called Penthrox (methoxyflurane) works better than a placebo for pain during minor sinus procedures. If you are having a simple sinus surgery or coblation procedure, you may be able to join.

Vancouver, British Columbia
NCT07742007Not yet recruiting· Phase 3
Methoxyflurane for sudden pain in the ER

This trial tests a pain-relief medicine called methoxyflurane for people who come to the emergency room with sudden, non-injury pain (like a headache or abdominal pain). It compares this medicine to the usual pain care. If you have severe pain and haven't taken painkillers recently, you might qualify.

Tours, CHRU de Tours
NCT07445737Not yet recruiting· Phase 3
Inhaled painkiller for heart attack pain in ambulance

This study tests a pain-relief medicine called methoxyflurane, which you inhale through a small hand-held device, to see if it helps reduce pain from a heart attack while you're on the way to the hospital. If you qualify, you would receive this medicine in the ambulance to help you feel more comfortable.

Bobigny
NCT07046572Recruiting
Pain relief for IUD insertion or endometrial biopsy

This trial tests if a pain-relief medication called methoxyflurane can help women who haven't had children before feel less pain during IUD insertion or a uterine biopsy. If you're getting one of these procedures and are not currently breastfeeding or using strong painkillers, this study might be for you.

Toronto, Ontario
NCT06899724Not yet recruiting
Pain relief during hysteroscopy for abnormal uterine bleeding

This trial tests a pain-relief medication called methoxyflurane during a hysteroscopy procedure to see if it helps reduce discomfort. It may be a good option if you need this procedure for abnormal or postmenopausal bleeding and cannot use standard sedation.

Saskatoon, Saskatchewan
NCT07857655Recruiting· Phase 4
Intraoperative methadone for pain after head and neck cancer surgery

This trial tests whether giving methadone during your head and neck cancer surgery helps control pain right after the operation. Methadone is a long-acting painkiller that might reduce pain for up to a day or more, potentially improving your recovery experience.

Portland, Oregon

Hear when a new All Adult Patients Undergoing an Otolaryngology Procedure With Inhaled Methoxyflurane as an Adjunct to Topical or Local Anesthesia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.